HIV testing strategies: Test performance is important, but not sufficient

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 2, 2011, Pages 207-214

  Cota, Gláucia Fernandes ^a,b   De Abreu Ferrari, Teresa Cristina ^a   De Sousa, Marcos Roberto ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Hospital Eduardo de Menezes   (Brazil)

Author keywords

diagnosis; HIV infections; meta analysis; population surveillance; predictive value of tests; sensitivity and specificity

Indexed keywords

BAYES THEOREM; BIOETHICS; COST EFFECTIVENESS ANALYSIS; GOLD STANDARD; HEALTH SURVEY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; NONHUMAN; PATIENT PREFERENCE; PRETEST POSTTEST DESIGN; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC ERROR; SYSTEMATIC REVIEW (TOPIC); TASK PERFORMANCE;

AIDS SERODIAGNOSIS; ALGORITHMS; BAYES THEOREM; COST-BENEFIT ANALYSIS; HIV INFECTIONS; HUMANS; MALE; META-ANALYSIS AS TOPIC; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 79952134886     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.165     Document Type: Review

References (49)

1. Banoo S, Bell D, Bossuyt P et al. Evaluation of diagnostic tests for infectious diseases: general principles. Nature Rev. 4(12 Suppl.) 20-32 (2006).
2. World Health Organization. WHO recommendation for HIV antibody testing. Wkly Epidemiol. Rec. 67, 145-152 (1992).
3. World Health Organization. Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol. Rec. 72, 81-88 (1997).
4. Palfreeman A, Fisher M, Ong E et al. Testing for HIV: concise guidance. Clin. Med. 9(5), 471-476 (2009).
5. Poljak M, Smit E, Ross J. 2008 European Guideline on HIV testing. Int. J. STD AIDS 20(2), 77-83 (2009).
6. Branson BM, Handsfield HH, Lampe MA et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm. Rep. 55(RR-14), 1-17; quiz CE1-CE4 (2006).
7. Rogstad K, Palfreeman A, Rooney G et al. UK national guidelines on HIV testing 2006. Int. J. STD AIDS 17(10), 668-676 (2006).
8. Butto S, Suligoi B, Fanales-Belasio E, Raimondo M. Laboratory diagnostics for HIV infection. Ann. Ist Sup. Sanità. 46(1), 24-33 (2010).
9. de Sousa MR, Ribeiro AL. Systematic review and meta-analysis of diagnostic and prognostic studies: a tutorial. Arq. Bras. Cardiol. 92(3), 35-45; 229-238 (2009).
10. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Systematic reviews of diagnostic test accuracy. Ann. Intern. Med. 149(12), 889-897 (2008).
11. Owen SM, Yang C, Spira T et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J. Clin. Microbiol. 46(5), 1588-1595 (2008). Shows evidence of problems with the 'reference standard' Western blot, and discusses alternative algorithms for HIV infection diagnosis.
12. Pai NP, Tulsky JP, Cohan D, Colford JM Jr, Reingold AL. Rapid point-of-care HIV testing in pregnant women: a systematic review and meta-analysis. Trop. Med. Int. Health 12(2), 162-173 (2007).
13. Kowalski J, Tu XM, Jia G, Pagano M. A comparative meta-analysis on the variability in test performance among FDA-licensed enzyme immunosorbent assays for HIV antibody testing. J. Clin. Epidemiol. 54(5), 448-461 (2001). Shows differences in performance of tests.
14. Schwartz JS, Dans PE, Kinosian BP. Human immunodeficiency virus test evaluation, performance, and use. Proposals to make good tests better. JAMA 259(17), 2574-2579 (1988).
15. Ly TD, Laperche S, Brennan C et al. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J. Virol. Methods 122(2), 185-194 (2004).
16. Butler IF, Pandrea I, Marx PA, Apetrei C. HIV genetic diversity: biological and public health consequences. Curr. HIV Res. 5(1), 23-45 (2007).
17. Ly TD, Martin L, Daghfal D et al. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. J. Clin. Microbiol. 39(9), 3122-3128 (2001).
18. Leeflang MM, Bossuyt PM, Irwig L. Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. J. Clin. Epidemiol. 62(1), 5-12 (2009). Discusses the effect of prevalence in the observed accuracy of a test.
19. Dinnes J, Deeks J, Kirby J, Roderick P. A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol. Assessm. 9(12), 1-113, iii (2005).
20. Wright RJ, Stringer JS. Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings. Am. J. Prev. Med. 27(1), 42-48 (2004).
21. Biesheuvel C, Irwig L, Bossuyt P. Observed differences in diagnostic test accuracy between patient subgroups: is it real or due to reference standard misclassification? Clin. Chem. 53(10), 1725-1729 (2007).
22. Anzala O, Sanders EJ, Kamali A et al. Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing. East African Med. J. 85(10), 500-504 (2008).
23. Clark JL, Coates TJ, Lescano AG et al. Different positive predictive values of commercially available human immunodeficiency virus enzyme-linked immunosorbent assays. Clin. Vaccine Immunol. 13(2), 302-303 (2006).
24. Lyamuya EF, Aboud S, Urassa WK et al. Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania. BMC Infect. Dis. 9, 19 (2009).
25. Vijayakumar TS, David S, Selvaraj K, Viswanathan T, Kannangai R, Sridharan G. Performance of a rapid immunochromatographic screening test for detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2: experience at a tertiary care hospital in South India. J. Clin. Microbiol. 43(8), 4194-4196 (2005).
26. Loy CT, Irwig L. Accuracy of diagnostic tests read with and without clinical information: a systematic review. JAMA 292(13), 1602-1609 (2004).
27. Greenwald JL, Burstein GR, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr. Infect. Dis. Rep. 8(2), 125-131 (2006).
28. Parmigiani G. Measuring uncertainty in complex decision analysis models. Stat. Methods Med. Res. 11(6), 513-537 (2002).
29. Bianchi MT, Alexander BM, Cash SS. Incorporating uncertainty into medical decision making: an approach to unexpected test results. Med. Decis. Making 29(1), 116-124 (2009).
30. Eichler HG, Kong SX, Gerth WC, Mavros P, Jonsson B. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 7(5), 518-528 (2004).
31. Elbasha EH, Messonnier ML. Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale. Health Econ. 13(1), 21-35 (2004).
32. Griffin S, Claxton K, Sculpher M. Decision analysis for resource allocation in health care. J. Health Serv. Res. Policy 13(Suppl. 3), 23-30 (2008).
33. Patel P, Mackellar D, Simmons P et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch. Intern. Med. 170(1), 66-74 (2010).
34. Hutchinson AB, Patel P, Sansom SL et al. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings. PLoS Med. 7(9), e1000342 (2010).
35. Sharma UK, Stramer SL, Wright DJ et al. Impact of changes in viral marker screening assays. Transfusion 43(2), 202-214 (2003).
36. Irwig L, McCaffery K, Salkeld G, Bossuyt P. Informed choice for screening: implications for evaluation. Br. Med. J. 332(7550), 1148-1150 (2006).
37. Conway PH, Clancy C. Comparative- Effectiveness Research - Implications of the Federal Coordinating Council's Report. N. Engl. J. Med. 361(4), 328-330 (2009).
38. Iglehart JK. Prioritizing Comparative- Effectiveness Research - IOM Recommendations. N. Engl. J. Med. 361(4), 325-328 (2009).
39. Wawer MJ, Gray RH, Sewankambo NK et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191(9), 1403-1409 (2005).
40. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J. Acq. Imm. Def. Synd. 39(4), 446-453 (2005).
41. Lyss SB, Branson BM, Kroc KA, Couture EF, Newman DR, Weinstein RA. Detecting unsuspected HIV infection with a rapid whole-blood HIV test in an urban emergency department. J. Acq. Imm. Def. Synd. 44(4), 435-442 (2007).
42. Branson BM. State of the art for diagnosis of HIV infection. Clin. Infect. Dis. 45(Suppl. 4), S221-S225 (2007). Comprehensive historical review of the evolution of HIV tests.
43. Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Ann. Intern. Med. 138(1), 40-44 (2003).
44. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med. Res. Method. 6, 9 (2006).
45. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br. Med. J. 339, b2700 (2009).
46. Ministério da Saúde. Recomendações para Terapia Anti-retroviral em Adultos Infectados pelo HIV: 2008. 2008 [cited 20 oct 2010]; [Brazilian guidelines for HIV therapy] www.aids.gov.br/sites/default/ files/consensoAdulto005c-2008montado.pdf
47. Vercauteren G. HIV assays: operational characteristics (Phase 1): report 15 antigen/ antibody. ELISAs: WHO http://whqlibdoc.who.int/publications/2004/ 9241592370.pdf
48. WHO. Guidance on testing and counselling for HIV in settings attended by people who inject drugs: improving access to treatment, care and prevention. Geneva: WHO Library Cataloguing in Publication Data www.wpro.who.int/ publications/PUB-9789290613985.htm
49. WHO. The World Health Report 2004: Changing History. Geneva: World Health Organization www.who.int/whr/2004/en/report04-en.pdf